|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 9/20 | (2006.01) |
| A61K 31/551 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| C07D 213/42 | (2006.01) |
| (11) | Number of the document | 2178513 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08771569.4 |
| Date of filing the European patent application | 2008-06-20 | |
| (97) | Date of publication of the European application | 2010-04-28 |
| (45) | Date of publication and mention of the grant of the patent | 2011-03-30 |
| (46) | Date of publication of the claims translation | 2011-07-25 |
| (86) | Number | PCT/US2008/067633 |
| Date | 2008-06-20 |
| (87) | Number | WO 2009/002829 |
| Date | 2008-12-31 |
| (30) | Number | Date | Country code |
| 945694 P | 2007-06-22 | US |
| (72) |
KOO, Otilia May Yue, US
NIKFAR, Faranak, US
DIAZ, Steven, US
|
| (73) |
Bristol-Myers Squibb Holdings Ireland,
Hinterbergstrasse 16, 6312 Steinhausen,
CH
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Tabletuotos kompozicijos, turinčios atazanavirą |
| TABLETED COMPOSITIONS CONTAINING ATAZANAVIR |
| Payment date | Validity (years) | Amount | |
| 2018-05-22 | 11 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2019-06-20 |